Other than the bias due to the small number, the difference could be explained by the fact that in most cases of our study molecular testing was performed only when loss of MMR gene expression was detected in tumor tissue (exceptions were made for very young patients with a personal history strongly suggestive of LS). This evidence concerns the gene MRC1 and neoplasm.